$INHD

INNO HOLDINGS INC.

No enriched coverage for $INHD in the last 7 days.

No SEC Form 4 filings for $INHD in the last 30 days.

See all $INHD insider activity →
Low

HK inno.N secures world-first EPD for K-CAB oral drug, advancing Korea ESG

HK inno.N (195940) announced that its K-CAB tablets 50 mg received the world's first Environmental Product Declaration (EPD) for an oral finished drug. The certification was awarded by EPD Global and IGSC, following a life cycle assessment under ISO standards. According to the company, this EPD will help meet ESG-related requirements and expand environmental assessments to other products.

INNO HOLDINGS INC. (INHD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

INNO HOLDINGS INC. (INHD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Mengshu Shao as Director and Chief Financial Officer Effective as of August 25, 2026, Ms. Mengshu Shao resign

EUDA Health Holdings Ltd: EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Thera

EUDA Health Holdings (NASDAQ: EUDA) said it signed a tri-party memorandum of understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to collaborate on developing, manufacturing, and commercializing next-generation iPSC-derived off-the-shelf oncology cell therapies. The company framed the deal as advancing its commercialization and distribution strategy.

INHD sentiment & insider activity

Recent INHD coverage spans financial news, corporate actions and market movers.

What's driving INHD

  • HK inno.N (195940) announced that its K-CAB tablets 50 mg received the world's first Environmental Product Declaration (EPD) for an oral finished drug. The certification was awarded by EPD Global and IGSC, following a life cycle assessment under ISO standards. According to the company, this EPD will help meet ESG-related requirements and expand environmental assessments to other products.

    biz.chosun.com · Sep 7, 2026

  • Leadership change may affect governance and short‑term stock sentiment.

    SEC EDGAR 8-K · Aug 31, 2026

  • EUDA Health Holdings (NASDAQ: EUDA) said it signed a tri-party memorandum of understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to collaborate on developing, manufacturing, and commercializing next-generation iPSC-derived off-the-shelf oncology cell therapies. The company framed the deal as advancing its commercialization and distribution strategy.

    finanznachrichten.de · Jul 28, 2026

  • The disclosed AI-sales-agent development deal is the immediate catalyst for INHD’s meme-like repricing, but it is explicitly early-stage and not yet deployed.

    finance.yahoo.com · Jun 10, 2026

  • Contracted development work and milestone-based payments create near-to-intermediate visibility into revenue timing and execution risk.

    SEC EDGAR 8-K · Jun 10, 2026

AlphAI scores every news story that mentions INHD with an AI model for sentiment and relevance, and aggregates insider trades from INNO HOLDINGS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $INHD

Score

HK inno.N secures world-first EPD for K-CAB oral drug, advancing Korea ESG

HK inno.N (195940) announced that its K-CAB tablets 50 mg received the world's first Environmental Product Declaration (EPD) for an oral finished drug. The certification was awarded by EPD Global and IGSC, following a life cycle assessment under ISO standards. According to the company, this EPD will help meet ESG-related requirements and expand environmental assessments to other products.

$INHDLow

INNO HOLDINGS INC. (INHD): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

INNO HOLDINGS INC. (INHD) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Departure of Mengshu Shao as Director and Chief Financial Officer Effective as of August 25, 2026, Ms. Mengshu Shao resign

EUDA Health Holdings Ltd: EUDA Health Signs Important Tri-Party Memorandum of Understanding with GO POSB Organoids and Shenzhen Inno to Significantly Advance Next-Generation iPSC and NK-TCR Cell Thera

EUDA Health Holdings (NASDAQ: EUDA) said it signed a tri-party memorandum of understanding with GO POSB Organoids and Shenzhen Innovation Immunotechnology to collaborate on developing, manufacturing, and commercializing next-generation iPSC-derived off-the-shelf oncology cell therapies. The company framed the deal as advancing its commercialization and distribution strategy.

$INHDMed

INNO HOLDINGS INC. (INHD): Entry into a Material Definitive Agreement

INNO HOLDINGS INC. (INHD) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.1 2 ex10-1.htm EX-10.1 Exhibit 10.1 The Company has redacted provisions or terms of this exhibit pursuant to Item 601(b)(10)(iv) of Regulation S-K. While portions of the exhibit have been redacted, this exhibit includes a prominent statement on the first page of the exhibit

$INHDMedAI 8/10

Inno Holdings Stock Is Trending After Surging 3,660% On Monday: What's Going On? - Inno Holdings (NASDAQ:

Inno Holdings (NASDAQ:INHD) shares jumped 3,660.95% on Monday, closing at $39.49, then fell 2.18% to $38.63 in after-hours trading, according to the report. The move followed a $3 million development services agreement to build an AI-powered used mobile phone sales agent platform with a Hong Kong AI provider. The project is still in early development and not yet commercially deployed.

$INHDMedAI 8/10

Inno Holdings Signs $3 Million Deal, Inhd Stock Surges 690%

Inno Holdings said it signed a $3 million development agreement to build an AI-powered sales platform for its used-mobile-phone business, with a Hong Kong AI services provider handling full development. The company expects the system to automate lead generation, recommendations, sales conversions and analytics. INHD shares rose about 690% on Monday after the announcement, following prior reverse splits.

Inno Holdings Inc. Announces 1-for-20 Reverse Stock Split in Ongoing Nasdaq Compliance Efforts

Inno Holdings Inc. (NASDAQ: INHD) has announced a 1-for-20 reverse stock split to become effective on May 4, 2026, aimed at maintaining compliance with Nasdaq's minimum bid price requirement. This action will reduce the outstanding shares from 50,413,224 to 2,520,662, with fractional shares rounded up. The company's common stock will continue to trade under the symbol "INHD" on Nasdaq.

INNO HOLDINGS INC. Approves 1-for-20 Reverse Stock Split Effective May 4, 2026

INNO HOLDINGS INC. has announced a 1-for-20 reverse stock split of its common stock, effective May 4, 2026, to ensure continued compliance with Nasdaq's listing requirements, particularly the minimum bid price. This action will reduce the number of outstanding shares from 50,413,224 to 2,520,662, potentially increasing the per-share value without altering the par value or authorized share count. While aiming for stability and compliance, the move might suggest underlying financial challenges and could impact stock liquidity and volatility.

Inno Holdings approves 1-for-20 reverse stock split By Investing.com

Inno Holdings Inc. announced its board of directors approved a 1-for-20 reverse stock split to become effective on May 4, 2026. This move aims to help the company comply with Nasdaq's minimum bid price requirement, as its stock has dropped significantly and is currently trading at $0.12. The split will reduce the number of outstanding shares and allow the company to maintain its Nasdaq listing.

Related tickers